AbbVie Slumps to 58th in Trading Volume Ranking as Stock Drops 1.09 Percent

On May 13, 2025, AbbVie Inc. (ABBV) experienced a significant decline, with its trading volume reaching $1.414 billion, marking a 41.73% decrease from the previous day. This placed AbbVie at the 58th position in terms of trading volume for the day. The stock price of AbbVie closed at a 1.09% decrease.

AbbVie Inc. has recently been in the spotlight due to its acquisition of Cerevel Therapeutics. The acquisition, announced on December 6, 2023, saw AbbVie agree to purchase Cerevel for $45 per share. This strategic move is expected to bolster AbbVie's portfolio and enhance its market position.

Additionally, institutional investors have shown interest in AbbVie. Lionshead Wealth Management LLC acquired a new position in AbbVie shares during the fourth quarter, indicating confidence in the company's future prospects. This investment is likely to have a positive impact on AbbVie's stock performance.